CD8A and neoplasm: Tim-3 and PD-1 are co-expressed on CD8 tumor-infiltrating lymphocytes (TILs) in mice bearing transplanted tumors as well as on NY-ESO-1-specific CD8+ T cells in patients with advanced melanoma [13].